AzTrials
AzTrials

Eating DisordersNCT07131852

Structural Brain Volumetry Changes in Eating Disorders.

An observational study of Eating Disorders and Psychiatric Comorbidities, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to investigate the relationship between structural brain changes and psychiatric comorbidities in individuals diagnosed with eating disorders (EDs). Read more about this study

Who is it for?
Ages 13 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Eating Disorders, Psychiatric Comorbidities
How many people
80 participants
Where
No sites listed yet
Study dates
10 Dec 2025to 20 May 2027
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: Study Setting: in Assuit university hospitals, Neuropsychiatry hospital Outpatient Clinic Study subjects: will include three groups of patients with eating disorders: Anorexia nervosa patients, Bulimia Nervosa patients, Binge-eating patients, and healthy control group they will be age and sex matched.

Who may be able to join

  • Age above 13 years.
  • DSM-5 diagnosis of an eating disorder (AN, BN, BED) confirmed by structured interview.

Who cannot join

  • Neurological or any previous psychiatric diagnosis.
  • IQ less than 70.
  • MRI contraindication (metal implants, pacemaker, severe claustrophobia).

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Alya O Mohamed, Master's degree contact

+20100859567

alya.ali268@gmail.com

About this study

The goal of this observational study is to investigate the relationship between structural brain changes and psychiatric comorbidities in individuals diagnosed with eating disorders (EDs). The main question it aims to answer is:

How are structural brain volumetric changes associated with psychiatric comorbidities in patients with eating disorders?

Participants with a clinical diagnosis of an eating disorder will undergo brain MRI scans for volumetric analysis and structured psychiatric assessments to identify comorbid conditions. Data will be collected cross-sectionally from patients receiving routine clinical care, with the aim of identifying neurobiological and psychiatric patterns that could inform targeted treatment and prevention strategies.

Read the detailed description

Eating disorders (EDs) are complex psychiatric conditions characterized by persistent disturbances in eating behaviors, body weight regulation, and self-perception, often accompanied by severe physical health consequences and high mortality rates (1). They typically emerge during adolescence or early adulthood but may develop at any age, with a multifactorial etiology involving genetic, neurobiological, psychological, and sociocultural influences (2).

The main diagnostic categories include anorexia nervosa (AN)-marked by significantly low body weight, intense fear of weight gain, and body image distortion; bulimia nervosa (BN)-characterized by recurrent binge eating followed by compensatory behaviors such as vomiting, fasting, or excessive exercise; and binge-eating disorder (BED)-involving recurrent episodes of excessive food intake without compensatory behaviors (3). Other specified feeding or eating disorders (OSFED) encompass clinically significant presentations not meeting full criteria for the above disorders.

In Egypt, eating disorders represent an under-recognized public health concern. Recent epidemiological studies have found that approximately 13.3% of Egyptian youth meet criteria for an ED, with BN being the most prevalent (8.4%) and BED affecting 1.4% (4). The apparent absence of AN cases in some surveys may reflect cultural perceptions of thinness, under-diagnosis, and stigma rather than true absence (5). Risk factors identified in Egyptian samples include high body mass index (BMI), exposure to Westernized beauty ideals, depression, and a history of psychological trauma (6).

Structural neuroimaging, particularly MRI, has revealed consistent alterations in ED patients. AN is often associated with global and regional gray matter reductions-particularly in the parietal, frontal, and temporal cortices-along with decreased subcortical and cerebellar volumes (7). BN has been linked to structural changes in frontal and striatal regions, potentially reflecting alterations in impulse control and reward processing (8). Some volumetric changes may partially reverse with nutritional rehabilitation, suggesting neuroplasticity (9).

Psychiatric comorbidities are highly prevalent in EDs, affecting more than 70% of patients (10). Anxiety disorders, mood disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and substance use disorders are common, often worsening symptom severity and complicating treatment (10, 11). OCD traits are especially frequent in AN, while BN shows strong associations with depression and anxiety.

This study aims to use structural MRI to investigate brain volumetric changes in individuals with eating disorders and to explore the relationship between these changes and psychiatric comorbidities, thereby contributing to a more comprehensive understanding of the neuropsychiatric profile of EDs.

Keywords
Eating Disorders, Anorexia Nervosa, Binge eating disorders, bulimia disorders
Medical subject headings
Feeding and Eating Disorders, Anorexia Nervosa, Binge-Eating Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07131852
Study groupRoleWhat they receive
Anorexia Nervosa PatientsNot described
Bulimia Nervosa PatientsNot described
Binge-Eating DisorderNot described
control groupNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To assess structural changes of brain volumetry in patients with eating disorders and compare with healthy controls.

    Measured: from enrollment till 18 months

Secondary outcomes (1)
  1. Highlight the extent of psychological disorders in such patients.

    Measured: From enrollment till 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Aug 2025
  2. Study start10 Dec 2025 (estimated)
  3. Primary completion20 Feb 2027 (estimated)
  4. Study completion20 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
80 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07131852
Sponsor's protocol ID
645210
Status last verified
Aug 2025
First submitted
13 Aug 2025
Last updated
20 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Eating Disorders and Psychiatric Comorbidities, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 20 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alya O Mohamed, Master's degree (+20100859567, alya.ali268@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To assess structural changes of brain volumetry in patients with eating disorders and compare with healthy controls. (time frame: from enrollment till 18 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in